GAROFALO HEALTH CARE SPA (GHC.MI) Fundamental Analysis & Valuation

BIT:GHC • IT0005345233

Current stock price

4.88 EUR
+0.06 (+1.24%)
Last:

This GHC.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. GHC.MI Profitability Analysis

1.1 Basic Checks

  • GHC had positive earnings in the past year.
  • In the past year GHC had a positive cash flow from operations.
  • In the past 5 years GHC has always been profitable.
  • Each year in the past 5 years GHC had a positive operating cash flow.
GHC.MI Yearly Net Income VS EBIT VS OCF VS FCFGHC.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

1.2 Ratios

  • With a decent Return On Assets value of 4.34%, GHC is doing good in the industry, outperforming 78.57% of the companies in the same industry.
  • GHC has a better Return On Equity (11.00%) than 64.29% of its industry peers.
  • GHC's Return On Invested Capital of 6.82% is fine compared to the rest of the industry. GHC outperforms 75.00% of its industry peers.
Industry RankSector Rank
ROA 4.34%
ROE 11%
ROIC 6.82%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GHC.MI Yearly ROA, ROE, ROICGHC.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • With an excellent Profit Margin value of 5.26%, GHC belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • GHC's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 9.97%, GHC belongs to the top of the industry, outperforming 89.29% of the companies in the same industry.
  • In the last couple of years the Operating Margin of GHC has grown nicely.
  • GHC's Gross Margin of 44.56% is fine compared to the rest of the industry. GHC outperforms 64.29% of its industry peers.
  • GHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.97%
PM (TTM) 5.26%
GM 44.57%
OM growth 3Y-4.41%
OM growth 5Y4.95%
PM growth 3Y-10.45%
PM growth 5Y-3.02%
GM growth 3Y-1.03%
GM growth 5Y-0.87%
GHC.MI Yearly Profit, Operating, Gross MarginsGHC.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. GHC.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GHC is destroying value.
  • GHC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GHC.MI Yearly Shares OutstandingGHC.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
GHC.MI Yearly Total Debt VS Total AssetsGHC.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • GHC has an Altman-Z score of 2.15. This is not the best score and indicates that GHC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • GHC has a Altman-Z score of 2.15. This is in the better half of the industry: GHC outperforms 67.86% of its industry peers.
  • GHC has a debt to FCF ratio of 14.60. This is a negative value and a sign of low solvency as GHC would need 14.60 years to pay back of all of its debts.
  • GHC's Debt to FCF ratio of 14.60 is on the low side compared to the rest of the industry. GHC is outperformed by 67.86% of its industry peers.
  • A Debt/Equity ratio of 0.66 indicates that GHC is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.66, GHC is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 14.6
Altman-Z 2.15
ROIC/WACC0.9
WACC7.58%
GHC.MI Yearly LT Debt VS Equity VS FCFGHC.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.23 indicates that GHC should not have too much problems paying its short term obligations.
  • The Current ratio of GHC (1.23) is better than 60.71% of its industry peers.
  • GHC has a Quick Ratio of 1.18. This is a normal value and indicates that GHC is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.18, GHC is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.18
GHC.MI Yearly Current Assets VS Current LiabilitesGHC.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. GHC.MI Growth Analysis

3.1 Past

  • GHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.05%, which is quite good.
  • GHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.93% yearly.
  • GHC shows a small growth in Revenue. In the last year, the Revenue has grown by 4.04%.
  • GHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.29% yearly.
EPS 1Y (TTM)19.05%
EPS 3Y3.24%
EPS 5Y12.93%
EPS Q2Q%43.45%
Revenue 1Y (TTM)4.04%
Revenue growth 3Y15.01%
Revenue growth 5Y18.29%
Sales Q2Q%4.21%

3.2 Future

  • The Earnings Per Share is expected to grow by 1.10% on average over the next years.
  • Based on estimates for the next years, GHC will show a small growth in Revenue. The Revenue will grow by 2.92% on average per year.
EPS Next Y-10%
EPS Next 2Y0%
EPS Next 3Y1.1%
EPS Next 5YN/A
Revenue Next Year4.91%
Revenue Next 2Y3.48%
Revenue Next 3Y2.92%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GHC.MI Yearly Revenue VS EstimatesGHC.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
GHC.MI Yearly EPS VS EstimatesGHC.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

4

4. GHC.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.62 indicates a reasonable valuation of GHC.
  • GHC's Price/Earnings ratio is a bit cheaper when compared to the industry. GHC is cheaper than 75.00% of the companies in the same industry.
  • GHC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.47.
  • GHC is valuated rather expensively with a Price/Forward Earnings ratio of 17.90.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GHC indicates a slightly more expensive valuation: GHC is more expensive than 64.29% of the companies listed in the same industry.
  • GHC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.62, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.62
Fwd PE 17.9
GHC.MI Price Earnings VS Forward Price EarningsGHC.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GHC is valued a bit cheaper than the industry average as 78.57% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GHC indicates a slightly more expensive valuation: GHC is more expensive than 75.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 28.39
EV/EBITDA 6.3
GHC.MI Per share dataGHC.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The decent profitability rating of GHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.9
EPS Next 2Y0%
EPS Next 3Y1.1%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. GHC.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.99%, GHC has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.84, GHC has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.81, GHC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.99%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 20.36% of the earnings are spent on dividend by GHC. This is a low number and sustainable payout ratio.
DP20.36%
EPS Next 2Y0%
EPS Next 3Y1.1%
GHC.MI Yearly Income VS Free CF VS DividendGHC.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
GHC.MI Dividend Payout.GHC.MI Dividend Payout, showing the Payout Ratio.GHC.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GHC.MI Fundamentals: All Metrics, Ratios and Statistics

GAROFALO HEALTH CARE SPA

BIT:GHC (4/23/2026, 7:00:00 PM)

4.88

+0.06 (+1.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-14
Earnings (Next)N/A
Inst Owners10.7%
Inst Owner ChangeN/A
Ins Owners63%
Ins Owner ChangeN/A
Market Cap440.18M
Revenue(TTM)708.47M
Net Income(TTM)37.27M
Analysts84
Price Target6.02 (23.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.99%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP20.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.61%
PT rev (3m)-10.61%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-15.62%
EPS NY rev (3m)-15.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)-0.49%
Valuation
Industry RankSector Rank
PE 11.62
Fwd PE 17.9
P/S 0.62
P/FCF 28.39
P/OCF 8.98
P/B 1.3
P/tB N/A
EV/EBITDA 6.3
EPS(TTM)0.42
EY8.61%
EPS(NY)0.27
Fwd EY5.59%
FCF(TTM)0.17
FCFY3.52%
OCF(TTM)0.54
OCFY11.14%
SpS7.85
BVpS3.76
TBVpS-0.38
PEG (NY)N/A
PEG (5Y)0.9
Graham Number5.95874 (22.11%)
Profitability
Industry RankSector Rank
ROA 4.34%
ROE 11%
ROCE 9.76%
ROIC 6.82%
ROICexc 7.11%
ROICexgc 15.3%
OM 9.97%
PM (TTM) 5.26%
GM 44.57%
FCFM 2.19%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-4.41%
OM growth 5Y4.95%
PM growth 3Y-10.45%
PM growth 5Y-3.02%
GM growth 3Y-1.03%
GM growth 5Y-0.87%
F-Score8
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 14.6
Debt/EBITDA 2.29
Cap/Depr 120.2%
Cap/Sales 4.73%
Interest Coverage 7.36
Cash Conversion 49.78%
Profit Quality 41.6%
Current Ratio 1.23
Quick Ratio 1.18
Altman-Z 2.15
F-Score8
WACC7.58%
ROIC/WACC0.9
Cap/Depr(3y)95.14%
Cap/Depr(5y)105.18%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.01%
Profit Quality(3y)95.32%
Profit Quality(5y)96.54%
High Growth Momentum
Growth
EPS 1Y (TTM)19.05%
EPS 3Y3.24%
EPS 5Y12.93%
EPS Q2Q%43.45%
EPS Next Y-10%
EPS Next 2Y0%
EPS Next 3Y1.1%
EPS Next 5YN/A
Revenue 1Y (TTM)4.04%
Revenue growth 3Y15.01%
Revenue growth 5Y18.29%
Sales Q2Q%4.21%
Revenue Next Year4.91%
Revenue Next 2Y3.48%
Revenue Next 3Y2.92%
Revenue Next 5YN/A
EBIT growth 1Y9.16%
EBIT growth 3Y9.94%
EBIT growth 5Y24.14%
EBIT Next Year68.22%
EBIT Next 3Y22.5%
EBIT Next 5YN/A
FCF growth 1Y15.72%
FCF growth 3Y-18.74%
FCF growth 5Y7.46%
OCF growth 1Y40.15%
OCF growth 3Y3.79%
OCF growth 5Y16.39%

GAROFALO HEALTH CARE SPA / GHC.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GAROFALO HEALTH CARE SPA (GHC.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to GHC.MI.


What is the valuation status for GHC stock?

ChartMill assigns a valuation rating of 4 / 10 to GAROFALO HEALTH CARE SPA (GHC.MI). This can be considered as Fairly Valued.


What is the profitability of GHC stock?

GAROFALO HEALTH CARE SPA (GHC.MI) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for GHC stock?

The Price/Earnings (PE) ratio for GAROFALO HEALTH CARE SPA (GHC.MI) is 11.62 and the Price/Book (PB) ratio is 1.3.


What is the expected EPS growth for GAROFALO HEALTH CARE SPA (GHC.MI) stock?

The Earnings per Share (EPS) of GAROFALO HEALTH CARE SPA (GHC.MI) is expected to decline by -10% in the next year.